Covid-19 roundup: Moderna CEO Stéphane Bancel becomes a billionaire; Novartis, Incyte pitch Jakafi PhIII to tackle severe cases
You can now add Moderna CEO Stéphane Bancel to the list of biotech billionaires.
Since investors began to understand the full scope of the coronavirus outbreak in late February, cash has flushed out of much of the stock market and into the handful of companies leading the fight for drugs and vaccines. That’s meant hundreds of millions for Moderna, the Flagship-backed company that emerged early as the world’s first best hope for a Covid-19 vaccine.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.